Received Date: September 06, 2016; Accepted Date: September 23, 2016; Published Date: September 30, 2016
Citation: Salah AM, Najwa D, Sihem M, et al. Current Epidemiology of Non-β-Lactam Antibiotics-Resistance in Escherichia coli from Animal Origins in Tunisia: A Paradigm of Multidrug Resistance. Arch Clin Microbiol. 2016, 7:5. doi:10.4172/1989-8436.100059
Copyright: © 2016 Salah AM et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Worldwide, resistance to antibiotics is a major health problem. Nowadays, multiples lines of evidence confirmed that food, in particular poultry products, may acts as reservoir of antibiotic-resistant bacteria or genetic elements encoding antibiotic resistance. Commensal Escherichia coli colonizing animals designated to human consummation (poultry, bovine, pork) often harbors mobile genetic elements that can be transferred in vivo to infectious pathogens. In addition, antibiotic resistant E. coli can be easily transferred to human via food chain. The objective of this work was to review the published data on the prevalence of antibiotic resistance and their genetic supports in E. coli of animal origins in Tunisia.
Antibiotic-resistance, Escherichia coli, animal, Tunisia
Antimicrobial resistance (AMR) is one of the most serious public health concerns of the twenty-first century. It is of particular concern the phenomenon of resistance carried out by some Gram- positive and negative bacteria such as methicillinresistant Staphylococcus aureus, glycopeptides-resistant Enterococcus faecium/Enterococcus faecalis and beta-lactamresistant Enterobacteriaceae . AMR has been largely limited to bacteria from human clinical setting; however, antibioticresistant bacteria of animal origin have been increasingly reported worldwide . Consequently, foods of animal origin are considered as reservoirs of antibiotic-resistant zoonotic bacteria. Nowadays, most experts agree that the contribution from food animals is a concern and many evidences seem to indicate that the importance of the food-animal reservoir is larger than we estimated a decade ago. Worldwide, beta-lactam-resistant Escherichia coli producing Extended Spectrum Beta-Lactamases (ESBLs), cephalosporinases or carbapenemases have been increasingly reported from food animals as well as from many wildlife species [3,4]. In Tunisia, high frequencies of antibiotic resistant E. coli from human as well as from animal or foods of animal origin have been increasingly reported during the last decade. Recently we have published a review reporting the occurrence of ESBL-producing E. coli from animal and foods of animal origin  highlighting the importance of this worrisome phenomenon in Tunisia. However, studies on resistance to other critically important antimicrobial families are also of interest to improve our knowledge about E. coli of animal origins. This might be useful not only for Tunisian health authorities and politician deciders but also for neighbour countries especially European countries that we share with them large economic exchanges including food products. Therefore, in this work we aimed to review the published data on the prevalence of AMR (other than beta-lactams resistance) and their genetic supports in E. coli of animal origins in Tunisia.
The level of the AMR problem in Tunisia
Aminoglycosides, tetracyclines, quinolones, trimethoprim, and sulfonamides are mainly used in the treatment of E. coli infections in humans and animals . Therefore, resistance to these antibiotics is of great concern. Nowadays, increasing rates of resistance are reported worldwide in Enterobacteriaceae especially in E. coli regardless of their animal or human origin [7,8]. In this context, all reported results about antibiotic susceptibility of E. coli isolates from animal sources in Tunisia showed high rates of resistance to the above-mentioned antibiotics [9,10]. Similarly to the global trend, particular high rates of resistance were observed against tetracycline, streptomycin, trimethoprim/sulfonamides, sulfonamides, and nalidixic acid. In unpublished survey in our Institute of Veterinary Research of Tunisia, we found that the level of resistance to different antimicrobials significantly varied according to the source of the isolates. E. coli isolates from poultry meats and faeces have the highest resistance rates than those from bovine and sheep. This finding might be a consequence of the selective pressures imposed by antimicrobial use in different food animal production and processing environments. In addition, the high levels of resistance in poultry may be partly due to the specific practices in avian industry, in which antimicrobials for disease control and prevention are overused [11,12].
Tetracycline resistance has been observed in 43% , 89% , and 95.2%  of E. coli isolates from food samples of animal origin (poultry, sheep, beef) (Table 1). This finding is in agreement to other studies reporting high rates of tetracyclineresistant E. coli from animal origins, especially in pig and chicken, ranging from 17.1 % (cattle) to 70.6 % (pigs) in different European countries (France, Italy, UK, Germany, Ireland, Greece) [8,14] and reaching 89.63 % (poultry) in China . This finding might be explained by the fact that tetracyclines, including chlortetracycline and minocycline, have been amongst the oldest antibiotics and have been used for growth promotion for poultry . In addition, its efficacy, low cost, and the lack of side effects make it the most popularly used antibiotic in livestock farming. Its widespread and imprudent use caused a high prevalence of tetracycline-resistant bacteria nowadays. Resistance to tetracycline can occur by various mechanisms including active efflux of tetracycline, the production of ribosomal protection proteins, decreased drug permeability, target mutation, and enzymatic degradation of the antibiotics . However, active efflux of tetracycline predominates in Enterobacteriaceae, and at least 26 tet-type genes have been reported to encode efflux-pumps . Amongst those determinants, tetA and tetB alleles have been mainly reported to predominate in E. coli regardless their origin, followed by tetC gene [15,18,19]. It can be assumed that the tetA gene can be spread more easily in the environment than other tetB and tetCgenes. Similarly, in the Tunisian studies, tetracycline-resistant E. coli mainly harboured tetA and tetB genes, being found in ranges of 37.9 % to 77.5% and 16.4% to 32%, respectively [9,10,13].
|Antibiotic agent||Rates of antibiotic resistance (%)||Detected genes|
|Tetracycline||43-95.2||17.1-89.63||tetA, tetB, tetC|
|Trim/sulf||29-80||9.0-70.6||sul1, sul2, sul3, dfrA1, dfrA17, dfrA5, dfrA12|
|Streptomycin||29-78||17.1-70.1||aadA1, aadA2, aadA5|
|Nalidixic acid||33 - 72.3||22-41||*gyrA mutations:Ser83Leu, Asp87Gly, Asp87Asn Asp87Tyr
*parC mutations: Ser80Ile, Glu84Gly, Ser80Arg
|Ciprofloxacin||7.0-19.9||10.9-62.5||qnrS1, qnrB5, qnrB19|
|Kanamycin||40||-||aph(3′)-Ia ; aac(6′)-Ib-cr|
Table 1: Frequencies and genetic supports of antimicrobial resistance of E. coli of animal origins in Tunisia
Resistance to aminosides and trimethoprim/ sulphonamides
Resistance to streptomycin, the combination trimethoprim/ sulfamethoxazole, and to sulfonamides are also high in E. coli of animal origins in our country. Indeed, resistance frequencies of 29% to 78%, 29% to 80%, and 39% to 87% have been reported for streptomycin, trimethorprim/sulfamethoxazole (SXT), and sulfonamide, respectively [9,10,13]. These high frequencies are very similar to reported results worldwide (SXT: 9.0% - 70.6%; Streptomycin: 17.1% - 70.1%) [8,14,15]. Moreover, worldwide, in each studied E. coli collection, frequencies of resistance to these three antibiotics are mainly very close, indicating that E. coli isolates are concurrently resistant against these antibiotics. According to genetic point of view, these results are expected since genes encoding streptomycin, trimethoprim, and sulfonamides-resistance are usually co-located on the same genetic vehicle such as integrons, plasmids and transposons . Sulfonamide resistance in Gram-negative bacilli generally rises from the presence of the sul1, sul2, and or sul3 genes [21,22]. Historically, sul1 and sul2 genes were the most prevalent ones in E. coli from animal and human origin, and sul3 gene scarcely detected. However, recently in Tunisia and in other part of the world, the sul3 gene has been emerged as an important determinant encoding sulfonamide resistance. This finding was attributed to another genetic phenomenon linked to a specific genetic rearrangement in the structure of the typical class 1 integron. Indeed, recently, many studies highlighted the increasing reports of lack of the sul1 gene from the 3’-CS (qacΔEsul1) of class 1 integron and its replacement by sul3 gene. More importantly, the sul3 gene was found in a transposase-like sequence, qacH-IS440-sul3-orf1-IS26 [23,24] that might have contributed to the maintenance and further spread of sul3 in E. coli isolates.
Resistance to streptomycin was mainly encoded by aadA type gene variants (aadA1, aadA2, aadA5) rarely by aadB alleles as reported in Tunisia and in others countries [9,10,13,25-27]. Interestingly, the different aadA alleles have been showed genetically linked to various dfrA alleles (dfrA1, dfrA17, dfrA5, dfrA12) on class 1 integron. This finding explains in part the close rates of resistance against trimethorprim and streptomycin in E. coli isolates reported by many studies [8-10,14,15]. Moreover, and considering the occurrence of both these genes (dfrA+aadA) on class 1 integron with 3’-CS containing sul1 or sul3 genes; such strains are therefore also resistant to sulfonamide . Kanamycin-resistance has been also reported, with moderate level (0-40%) and encoded by aph(3′)-Ia ; aac(6′)- Ib-cr genes. In contrast to aforementioned rates of antimicrobial resistance, rate of gentamicin resistance was very low, being less than 2 % and mainly encoded by the aac(3)-II gene [9,10,13,25,26,29].
Resistance to fluoroquinolones
In Tunisia, non cephalosporins-resistant isolates showed resistance to nalidixic acid, which varied from 33% to 72.3%, and ciprofloxacin-resistance ranging from 7% to 19.9% [9,10,13]. In the world, the prevalence of fluoro-quinolones resistance in E. coli from poultry has been increasingly reported. The mechanisms attributed to quinolones resistance are principally related to mutations in the quinolone resistance determinants regions (QRDR) of gyrA and parC genes . Ser83Leu, Asp87Gly, Asp87Asn and Asp87Tyr substitutions in GyrA protein have been reported, and Ser80Ile, Glu84Gly and Ser80Arg in ParC protein [26,31]. Plasmid-mediated-quinolone resistance (PMQR) was also found to contribute to the increase of quinolone resistance among E. coli isolates . qnrS1, qnrB5 and qnrB19 genes have been reported respectively in chicken samples and faecal samples from healthy dog in Tunisia [29,31]. The aac(6’)-Ib-cr gene, which encodes a variant of the widespread aminoglycoside acetyltransferase ACC(6’)-Ib was also detected in chicken and poultry meat samples [10,29].
Worldwide, a global analysis showed high resistance rates against tetracycline, trimethorprim/sulfamethoxazole, streptomycin and quinolones antibiotics. E. coli from pig and poultry were the most resistant ones. This finding is linked to the specific production systems of pig and poultry, where thousands of organisms are assembled in crowded limited space. In such industrialized environments, animals are stressed and highly susceptible to bacterial and viral infections. Consequently, and to overcome economic losses, application of antimicrobial substances is common in pig and poultry farms. Therefore, these antibiotic-rich environments become ideal settings of crosstransmission of resistant E. coli isolates and genetic elements encoding antibiotic resistance (integrons, plasmids). E. coli of animal and food-producing animals in Tunisia seems to be in the global way of acquiring multi-drug-resistance. The high rates of resistance to tetracycline, streptomycin, quinolones/ fluoroquinolones and trimethoprim/sulfamethoxazole are compared to the worldwide situation.
All authors have contributed equally to the realization of this work. None of the contributing authors has any conflict of interests relevant to the subject matter or materials discussed in the manuscript. No funding or other financial support was received.
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : December 15, 2018